Department of Molecular and Integrative Physiology, University of Illinois, 524 Burrill Hall, 407 South Goodwin Avenue, Urbana, Illinois 61801-3704, USA.
Endocrinology. 2011 Nov;152(11):4336-49. doi: 10.1210/en.2011-1100. Epub 2011 Aug 23.
Estrogen receptor (ER) is a key regulator of mammary gland development and is also implicated in breast tumorigenesis. Because ER-mediated activities depend critically on coregulator partner proteins, we have investigated the consequences of reduction or loss of function of the coregulator repressor of ER activity (REA) by conditionally deleting one allele or both alleles of the REA gene at different stages of mammary gland development. Notably, we find that heterozygosity and nullizygosity for REA result in very different mammary phenotypes and that REA has essential roles in the distinct morphogenesis and functions of the mammary gland at different stages of development, pregnancy, and lactation. During puberty, mice homozygous null for REA in the mammary gland (REAf/f PRcre/+) showed severely impaired mammary ductal elongation and morphogenesis, whereas mice heterozygous for REA (REAf/+ PRcre/+) displayed accelerated mammary ductal elongation, increased numbers of terminal end buds, and up-regulation of amphiregulin, the major paracrine mediator of estrogen-induced ductal morphogenesis. During pregnancy and lactation, mice with homozygous REA gene deletion in mammary epithelium (REAf/f whey acidic protein-Cre) showed a loss of lobuloalveolar structures and increased apoptosis of mammary alveolar epithelium, leading to impaired milk production and significant reduction in growth of their offspring, whereas body weights of the offspring nursed by females heterozygous for REA were slightly greater than those of control mice. Our findings reveal that REA is essential for mammary gland development and has a gene dosage-dependent role in the regulation of stage-specific physiological functions of the mammary gland.
雌激素受体 (ER) 是乳腺发育的关键调节因子,也与乳腺癌的发生有关。由于 ER 介导的活性严重依赖于共调节剂伴侣蛋白,我们通过在乳腺发育的不同阶段条件性地删除 REA 基因的一个或两个等位基因,研究了共调节剂 ER 活性抑制剂 (REA) 的减少或功能丧失的后果。值得注意的是,我们发现 REA 的杂合性和缺失性导致非常不同的乳腺表型,并且 REA 在乳腺发育的不同阶段、怀孕和哺乳过程中的不同形态发生和功能中具有重要作用。在青春期,乳腺中 REA 基因杂合缺失的小鼠(REAf/f PRcre/+)表现出严重的乳腺导管伸长和形态发生受损,而 REA 杂合的小鼠(REAf/+ PRcre/+)则表现出乳腺导管伸长加速、终末芽数量增加以及 Amphiregulin 的上调, Amphiregulin 是雌激素诱导的导管形态发生的主要旁分泌介质。在怀孕和哺乳期,乳腺上皮中 REA 基因缺失的小鼠(REAf/f whey acidic protein-Cre)表现出小叶间腔结构丧失和乳腺腺泡上皮细胞凋亡增加,导致产奶能力受损和后代生长显著减少,而接受 REA 杂合雌性哺乳的后代体重略高于对照小鼠。我们的研究结果表明,REA 对于乳腺发育是必不可少的,并且在调节乳腺特定生理功能方面具有基因剂量依赖性作用。